-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Lucid Diagnostics Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2021 to 2023.
- Lucid Diagnostics Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $1.2M, a 14.2% decline year-over-year.
- Lucid Diagnostics Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $4.35M, a 63.5% decline year-over-year.
- Lucid Diagnostics Inc. annual Share-based Payment Arrangement, Expense for 2023 was $6.82M, a 54.5% decline from 2022.
- Lucid Diagnostics Inc. annual Share-based Payment Arrangement, Expense for 2022 was $15M, a 56.2% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)